Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)

Clinical trial NCT03714763 · UNKNOWN

Trial details

NCT number: NCT03714763
Sponsor: Zhebao Wu
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Pituitary Adenoma

Start date: 2018-11-01
Primary completion: 2021-11-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.